xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma.
Momoko Yoshikawa, K. Tsuchihashi, T. Ishimoto, Toshifumi Yae, T. Motohara, E. Sugihara, N. Onishi, T. Masuko, K. Yoshizawa, S. Kawashiri, M. Mukai, S. Asoda, H. Kawana, T. Nakagawa, H. Saya, O. Nagano
Cancer Research